Understand the interpretation of Down syndrome screening results, as well as the meanings of risk ratio and cutoff values.

The results of the Down Syndrome screening are used to assess the risk of fetal illness by combining pregnant women’s serological indicators, gestational age, age, and weight.

Prenatal screening for genetic metabolic disorders is a simple, quick, and cost-effective blood test that can be performed shortly after a newborn’s birth to early detect any congenital genetic diseases. Early diagnosis allows for timely treatment, promoting healthy growth.

Prenatal screening shows a high risk of Down Syndrome; further amniocentesis is needed for confirmation

Down Syndrome is a common chromosomal abnormality disease that can be assessed for fetal risk through prenatal screening. If the screening results indicate a high risk, it is recommended to undergo amniocentesis for further confirmation.

An overview of the definition and potential risks associated with Down syndrome

Explore the different purposes and testing methods of neonatal disease screening and Down syndrome screening, as well as the importance of gestational diabetes screening.

Understand the implications of high-risk trisomy 21 screening and obtain management advice.

Explore the meaning of the Down Syndrome risk score and its application in prenatal screening.

A high risk value of 1 in 15 in the 21-trisomy screening indicates that there is a 1 in 15 chance of having a child with Down syndrome. This screening result suggests a higher likelihood of the baby having Down syndrome. The specific risk value calculation considers various factors, including the pregnant woman’s age, weight, gestational age, and levels of serum markers (such as AFP and HCG). If the screening result indicates a high risk, it is usually recommended to undergo amniocentesis or other more accurate diagnostic tests to determine the presence of 21-trisomy syndrome or other chromosomal abnormalities.